- 同
- HAV,(Havrix, Vaqta
WordNet
- a harmful or corrupting agency; "bigotry is a virus that must not be allowed to spread"; "the virus of jealousy is latent in everyone"
- (virology) ultramicroscopic infectious agent that replicates itself only within cells of living hosts; many are pathogenic; a piece of nucleic acid (DNA or RNA) wrapped in a thin coat of protein
- a software program capable of reproducing itself and usually capable of causing great harm to files or other programs on the same computer; "a true virus cannot spread to another computer without human assistance" (同)computer virus
- immunogen consisting of a suspension of weakened or dead pathogenic cells injected in order to stimulate the production of antibodies (同)vaccinum
- the 1st letter of the Roman alphabet (同)a
- the blood group whose red cells carry the A antigen (同)type_A, group A
- inflammation of the liver caused by a virus or a toxin
PrepTutorEJDIC
- ビールス,ろ過性病原体
- 牛痘種,痘苗(牛痘を起こすビールスで,天然痘予防のために人体に接種される) / (伝染病の病原菌から作った)ワクチン
- answer / ampere
- 肝[臓]炎
- arsenicの化学記号
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Estimating seroprevalence of vaccine-preventable infections: is it worth standardizing the serological outcomes to adjust for different assays and laboratories?
- Kafatos G1, Andrews N1, McCONWAY KJ2, Anastassopoulou C3, Barbara C4, DE Ory F5, Johansen K6, Mossong J7, Prosenc K8, Vranckx R9, Nardone A1, Pebody R1, Farrington P2.
- Epidemiology and infection.Epidemiol Infect.2015 Aug;143(11):2269-78. doi: 10.1017/S095026881400301X. Epub 2014 Nov 25.
- The aim of the European Sero-Epidemiology Network 2 (ESEN2) project was to estimate age-specific seroprevalence for a number of vaccine-preventable diseases in Europe. To achieve this serosurveys were collected by 22 national laboratories. To adjust for a variety of laboratory methods and assays, al
- PMID 25420586
- Trends in Disease and Complications of Hepatitis A Virus Infection in the United States, 1999-2011: A New Concern for Adults.
- Ly KN1, Klevens RM1.
- The Journal of infectious diseases.J Infect Dis.2015 Jul 15;212(2):176-82. doi: 10.1093/infdis/jiu834. Epub 2015 Jan 29.
- BACKGROUND: In recent years, few US adults have had exposure and resultant immunity to hepatitis A virus (HAV). Further, persons with liver disease have an increased risk of adverse consequences if they are infected with HAV.METHODS: This study used 1999-2011 National Notifiable Diseases Surveillanc
- PMID 25637352
- The Changing Epidemiology of Hepatitis A Virus Infections in the United States.
- Nelson KE1.
- The Journal of infectious diseases.J Infect Dis.2015 Jul 15;212(2):171-2. doi: 10.1093/infdis/jiu835. Epub 2015 Jan 29.
- PMID 25637351
Japanese Journal
- ビフィズス菌を利用したC型肝炎経口ワクチンの開発 (特集 C型肝炎治療update : 基礎・臨床研究の最新知見) -- (基礎研究の進歩)
- The J6JFH1 Strain of Hepatitis C Virus Infects Human B-Cells with Low Replication Efficacy
- Nakai Masato,Seya Tsukasa,Matsumoto Misako,Shimotohno Kunitada,Sakamoto Naoya,Aly Hussein H.
- Viral Immunology 27(6), 285-294, 2014-08
- … Hepatitis C virus (HCV) infection is a serious health problem worldwide that can lead to hepatocellular carcinoma or end-stage liver disease. … Current treatment with pegylated interferon, ribavirin, and NS3/4A protease inhibitor would lead to a good prognosis in a large population of patients, but there is still no effective vaccine for HCV. …
- NAID 120005468145
- The Impact of Vaccines to Prevent Vertically Transmitted Infection
- 順天堂醫事雑誌 60(5), 468-468, 2014
- … There is a notable background to this outbreak of rubella, including the history of rubella vaccination, which needs to be understood.In Japan, rubella vaccine was first administered in 1976 for only girls in junior high schools. … Although MMR vaccine was started for both boys and girls in 1989, it was canceled in 1993 due to anxiety about its side effects, such as aseptic meningitis. …
- NAID 130005064592
Related Links
- McMahon BJ. Epidemiology and natural history of hepatitis B. Semin Liver Dis 2005; 25 Suppl 1:3. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J ...
- ... and for people at high risk for infection with the virus. The hepatitis A vaccine is given as two shots, six months apart. The hepatitis A vaccine also comes in a combination form, containing both hepatitis A and B vaccine, that ...
★リンクテーブル★
[★]
- 同
- hepatitis A virus vaccine
[★]
- 同
- hepatitis A virus vaccine
[★]
[★]
- 関
- adenoviral、adenovirus
[★]
ウイルス